PhaseV has formed a strategic collaboration with Alimentiv for supporting the design and execution of adaptive clinical ...

On World Cancer Day, the UK Government has announced plans to launch a national trial to cut cancer screening wait times.

Makerere University, the Uganda Virus Research Institute and the WHO got the Uganda Ebola vaccine trial ready for dosing in ...

Aplagon has secured a financing of €7m ($7.24m) to advance APAC, to primarily support the initiation of a Phase IIa trial for ...

Experts believe that pharma will continue as normal due to the scientific justification of running diverse clinical trials.

The colon cancer BRAFF mutation study is one of the first to be initiated under the FDA’s Project FrontRunner.

Entrada has secured authorisation from the UK's MHRA to commence ELEVATE-44-201, to evaluate ENTR-601-44, aimed at treating DMD.

In partnership with global institutions, IIT Guwahati researchers have developed an adaptive multi-stage trial method.

A study from the University of Birmingham has indicated that digoxin could be used to treat senior individuals with heart ...

Medical Devices conference, held in Munich, Germany on 28-29 January, was filled with sessions that dug into the minutiae of ...

According to leading data and analytics company GlobalData’s Clinical Trials Database, over the past 20 years trial activity ...

Paradigm Biopharmaceuticals has selected Advanced Clinical as the CRO to support its Phase III trial, PARA_OA_012, focused on ...